Loading...

Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.

Plan to take Practo to 100 cities in India

Image

10-Mar-16 Practo, the Bengaluru headquartered online healthcare platform, has seen very rapid growth over the last eight years with a presence in 35 Indian cities and in countries such as Singapore, Malaysia, Indonesia and the Philippines. Backed by USD120 mn investment capital Practo aims to expand into 100 cities in India and grow as a global digital healthcare company. [Image: Notey]

Read More

Korean start-ups awakened to medical AI

Image

11-Mar-16 In Korea, Artificial Intelligence (AI) is an underdeveloped and poorly invested sector. But in hospitals, AI is used for various purposes such as analyzing medical videos to pinpoint diseases and suggesting optimized treatment plans. In Korea, various venture startups are developing healthcare technologies based on AI, including Buno, Lunit and Neofect. [image: Business Korea]

Read More

Kidney failures doubled in 15 years in India

Image

11-Mar-16 The number of Indians suffering from kidney failures has doubled in the last one and a half decades. Diabetes is believed to be the most common cause and with its growth, the number of kidney patients is likely to rise. [image: Zee News]

Read More

LatAm ageing populations: Burden for some, gold mine for others

Image

09-Mar-16 Latin America is experiencing significant ageing of its population. The confluence of continued technological progress and dropping fertility rates has led to growing concerns about the sustainability of publicly financed healthcare. Private providers have the opportunity to capitalize on this trend, pioneering the patient-centric movement focused on improving the quality of life for the higher age classes. [image: Red Raiders]

Read More

China requires generics to obtain brand-name drug quality

Image

08-Mar-16 According to a circular issued by China's State Council, generic drugs already available on the market should be assessed on whether they are consistent with brand-name drugs, and if they could be used clinically. Crucially, generics that pass the assessment will be included under national insurance coverage. [image: People's Daily Online]

Read More
Share